TECHNOLOGY & SOFTWARE
facilitating personalised care and supporting social engagement. Ayla – our digital CST assistant – empowers health and care staff to deliver best-in-class dementia care with confidence and ease.
Developed to improve access to CST, Ayla includes 14 full digital CST sessions and over 180 expertly validated activities to deliver equivalent outcomes to traditional CST.
“Poor patient access, unwanted side effects, and high costs – up to £25,000 per patient per year – make drug-only therapies an unscalable solution for many people living with dementia.”
Co-designed with care providers and people living with dementia, Ayla is built for simplicity and impact. With just a few hours of training, care professionals and activity coordinators are equipped to deliver a NICE-recommended therapy that tangibly improves lives. Ayla fits easily into existing routines, helping staff confidently run meaningful CST sessions without overhauling their day. It empowers the frontline to deliver person-centred care that’s not only scalable, but deeply human.
The results are remarkable. In just seven weeks, residents show measurable improvements in mood, memory, and social connection. Quality-of-life scores rise across the board, and subjective cognition improves significantly. Facilitators oſten report greater confidence, residents feel more connected, and 100% of staff said they would recommend Ayla. Most powerfully, residents on average rate their experience 9.6 out of 10, with 90% saying they’d recommend CST to others. These rapid, meaningful outcomes offer strong, inspection-ready evidence aligned with the
CQC’s new Single Assessment Framework (SAF), demonstrating what’s possible when the right tools meet the right people, at the right time.
With upcoming CQC inspections now structured around the updated SAF, care homes are under increasing pressure to ensure evidence is clear, consistent, and aligned with the six key evidence categories. Ayla supports teams by enabling seamless, real-time recording of resident observations, ensuring care is properly tracked against individual needs, care plans, and national guidelines. Whether it's documenting session outcomes, flagging concerns, or evidencing person-centred care, Ayla helps staff feel inspection-ready with confident, compliant record-keeping built into daily practice.
MOVING BEYOND DRUG-BASED THERAPIES
As seen in the 10-year plan, the national conversation around dementia has been overly focused on drug-based therapies. While they play an invaluable role in dementia care, they are not the whole story.
Poor patient access, unwanted side effects, and high costs – up to £25,000 per patient per year – make drug-only therapies an unscalable solution for many people living with dementia.
With a projected 1.4 million people in the UK expected to be living with dementia in 2040, effective and scalable treatments are a matter of national urgency.
To truly tackle the dementia challenge, we must change the conversation around how we treat dementia. We must move beyond the limitations and embrace the full range of evidence- based therapies available today. Digital CST platforms like Ayla are not just a promising alternative but a proven, practical solution that can help us meet the dementia challenge head-on, so that every individual living with dementia can lead a life with dignity, connection, and purpose.
www.brain-plus.com
23
www.tomorrowscare.co.uk
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40
